All terms in BAO
| Label | Id | Description |
|---|---|---|
| EC 3.2.1.* (glycosidase) inhibitor | CHEBI_52424 | |
| cell culture method | BAO_0002647 | |
| assay supporting method | BAO_0002429 | [Assay supporting methods describe the methods to prepare, generate or post-process the assay system or assay screening process. Such methods include the sample preparation, labeling, data processing, etc., which are required to performing the assay, but do not constitute the actual assay (design method).] |
| EC 3.2.1.20 (alpha-glucosidase) inhibitor | CHEBI_67239 | |
| one cell type | BAO_0002648 | |
| epididymitis | DOID_9402 | |
| male reproductive system disease | DOID_48 | [A reproductive system disease that affects male reproductive organs.] |
| co-culture | BAO_0002649 | |
| epididymo-orchitis | DOID_9401 | |
| hypopituitarism | DOID_9406 | [A pituitary gland disease characterized by the decreased secretion of one or more of the eight hormones normally produced by the pituitary gland.] |
| pituitary gland disease | DOID_53 | [An endocrine system disease that is located_in the pituitary gland.] |
| EC 3.2.1.48 (sucrose alpha-glucosidase) inhibitor | CHEBI_67231 | |
| regulation of RNA splicing | GO_0043484 | [Any process that modulates the frequency, rate or extent of RNA splicing, the process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA.] |
| regulation of gene expression | GO_0010468 | [Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.] |
| EC 3.2.1.45 (glucosylceramidase) inhibitor | CHEBI_67230 | |
| cyclin B1-luciferin 4-monooxygenase | BAO_0002641 | |
| diabetes insipidus | DOID_9409 | |
| kidney disease | DOID_557 | [A urinary system disease that is located_in the kidney.] |
| primary antibody | BAO_0002643 | [The role of an antibody to detect and bind a specific antigen in a sample (cell, tissue, protein blot).] |
| platelet activation | GO_0030168 | [A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.] |